// App-Quantinova.ai

BSH19‐PO‐068 : Severe Hepatotoxicity Following Tyrosine Kinase Inhibitor Use for the Treatment of Chronic Myeloid Leukaemia in Pregnancy

Researchers

Presenter

  • M. Narayanan

Principal Investigators

  • A. Fletcher

Medical Centers

  • Department of Haematology, Castle Hill Hospital, Hull and East Yorkshire Hospitals, NHS Trust, Hull, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Fulminant hepatic failure

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

  • Interferon

Drug/Treatment

  • Flopen

  • Metronidazole

  • Tacrolimus

  • Interferon

  • Nilotinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved